JAK2 and acute lymphoblastic leukemia: A genetically diverse B-ALL subgroup comprises cases with rearrangements affecting genes involved in cytokine-receptor or kinase signaling, such as ABL1, ABL2, PDGFRB, CSF1R, JAK2, EPOR, and CRLF2 [6,7].